VEGFA and respiratory system disorder: siRNA targeting Vascular Endothelial Growth Factor (VEGF) has shown promise in suppressing tumor growth in lung cancer, while pDNA nanoparticles withstand the pulmonary environment, proving viable for treating respiratory diseases [53].